Gsa Capital Partners LLP Danaher Corp Transaction History

Gsa Capital Partners LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $242,147 - $279,770	1,010 New	1,010 $254,000
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $1.01 Million - $1.23 Million	-3,704 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$225.08 - $271.69 $833,696 - $1.01 Million	3,704 New	3,704 $994,000
Q1 2021 May 10, 2021	SELL	$212.38 - $245.9 $523,516 - $606,143	-2,465 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$212.5 - $245.46 $523,812 - $605,058	2,465 New	2,465 $548,000
Q4 2018 Feb 12, 2019	SELL	$94.85 - $109.54 $811,157 - $936,786	-8,552 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $243,460 - $270,180	2,481 Added 40.87%	8,552 $929,000
Q2 2018 Aug 09, 2018	SELL	$96.1 - $103.24 $1.11 Million - $1.19 Million	-11,529 Reduced 65.51%	6,071 $599,000
Q1 2018 May 11, 2018	BUY	$92.16 - $103.8 $911,554 - $1.03 Million	9,891 Added 128.3%	17,600 $1.72 Million
Q4 2017 Feb 14, 2018	BUY	$85.26 - $94.62 $16,625 - $18,450	195 Added 2.6%	7,709 $716,000
Q3 2017 Nov 20, 2017	BUY	$79.29 - $88.45 $595,785 - $664,613	7,514	7,514 $645,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.